Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa Part I: Topical and Systemic Medical Therapies

Hidradenitis suppurativa (HS) is an oftentimes debilitating condition that presents with painful nodules, abscesses, and sinus tracts. This condition is challenging to treat, in part because the pathogenesis of the condition is incompletely understood but also because there are limited therapeutic o...

Descripción completa

Detalles Bibliográficos
Autores principales: Fragoso, Natalie M., Masson, Rahul, Gillenwater, T. Justin, Shi, Vivian Y., Hsiao, Jennifer L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366071/
https://www.ncbi.nlm.nih.gov/pubmed/37402031
http://dx.doi.org/10.1007/s13555-023-00956-6
_version_ 1785077091935453184
author Fragoso, Natalie M.
Masson, Rahul
Gillenwater, T. Justin
Shi, Vivian Y.
Hsiao, Jennifer L.
author_facet Fragoso, Natalie M.
Masson, Rahul
Gillenwater, T. Justin
Shi, Vivian Y.
Hsiao, Jennifer L.
author_sort Fragoso, Natalie M.
collection PubMed
description Hidradenitis suppurativa (HS) is an oftentimes debilitating condition that presents with painful nodules, abscesses, and sinus tracts. This condition is challenging to treat, in part because the pathogenesis of the condition is incompletely understood but also because there are limited therapeutic options. HS research is undergoing explosive growth with multiple new molecular pathways under study, which will hopefully lead to improved disease control for patients. Part I of this review will provide an overview of the emerging topical and systemic therapies under investigation for HS.
format Online
Article
Text
id pubmed-10366071
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-103660712023-07-26 Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa Part I: Topical and Systemic Medical Therapies Fragoso, Natalie M. Masson, Rahul Gillenwater, T. Justin Shi, Vivian Y. Hsiao, Jennifer L. Dermatol Ther (Heidelb) Review Hidradenitis suppurativa (HS) is an oftentimes debilitating condition that presents with painful nodules, abscesses, and sinus tracts. This condition is challenging to treat, in part because the pathogenesis of the condition is incompletely understood but also because there are limited therapeutic options. HS research is undergoing explosive growth with multiple new molecular pathways under study, which will hopefully lead to improved disease control for patients. Part I of this review will provide an overview of the emerging topical and systemic therapies under investigation for HS. Springer Healthcare 2023-07-04 /pmc/articles/PMC10366071/ /pubmed/37402031 http://dx.doi.org/10.1007/s13555-023-00956-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Review
Fragoso, Natalie M.
Masson, Rahul
Gillenwater, T. Justin
Shi, Vivian Y.
Hsiao, Jennifer L.
Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa Part I: Topical and Systemic Medical Therapies
title Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa Part I: Topical and Systemic Medical Therapies
title_full Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa Part I: Topical and Systemic Medical Therapies
title_fullStr Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa Part I: Topical and Systemic Medical Therapies
title_full_unstemmed Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa Part I: Topical and Systemic Medical Therapies
title_short Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa Part I: Topical and Systemic Medical Therapies
title_sort emerging treatments and the clinical trial landscape for hidradenitis suppurativa part i: topical and systemic medical therapies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366071/
https://www.ncbi.nlm.nih.gov/pubmed/37402031
http://dx.doi.org/10.1007/s13555-023-00956-6
work_keys_str_mv AT fragosonataliem emergingtreatmentsandtheclinicaltriallandscapeforhidradenitissuppurativapartitopicalandsystemicmedicaltherapies
AT massonrahul emergingtreatmentsandtheclinicaltriallandscapeforhidradenitissuppurativapartitopicalandsystemicmedicaltherapies
AT gillenwatertjustin emergingtreatmentsandtheclinicaltriallandscapeforhidradenitissuppurativapartitopicalandsystemicmedicaltherapies
AT shiviviany emergingtreatmentsandtheclinicaltriallandscapeforhidradenitissuppurativapartitopicalandsystemicmedicaltherapies
AT hsiaojenniferl emergingtreatmentsandtheclinicaltriallandscapeforhidradenitissuppurativapartitopicalandsystemicmedicaltherapies

Ejemplares similares